Clinical trial · Observational
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer
NCT00681694CI-TRIAL-00003409unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| brachytherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- MRBT
- description
- MRI-assisted brachytherapy, the experimental arm
- interventionNames
- Radiation: brachytherapy
- label
- USBT1
- description
- Standard ultrasound-guided brachytherapy performed by group 1 (control arm 1)
- interventionNames
- Radiation: brachytherapy
- label
- USBT2
- description
- Standard ultrasound-guided brachytherapy performed by group 2 (control group 2)
- interventionNames
- Radiation: brachytherapy
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pathological diagnosis of an adenocarcinoma of the prostate * 18 years of age or older * Prior choice of either standard brachytherapy or MRIGPB as primary treatment Exclusion Criteria: * Prior primary therapy (surgery or external beam radiation) for prostate cancer * Current hormone ablation therapy
References
Publications (0)
Data not yet available
No reference posted for this study.